Abstract:Standard laboratory cultures have long been known to hinder activation of specific gene clusters which in turn hamper production of secondary metabolites with unique properties due to lack of innovation or the inability to trigger cryptic gene clusters’ expression. Due to challenges related to the avoidance of the isolation of replicated metabolites, resistance-developing pathogens are to be addressed by the scientific community worldwide in order to progress with novel and potent compounds which could further be developed in the future for pharmaceutical usage. This study reports the isolation of novel cryptic antibiotics from a marine fungus Penicillium sp. BB1122 collected from Zhoushan coast by applying the “metal-stress” strategy, here referring to the heavy metal cobalt (6 mM). High-performance liquid chromatography-guided isolation of four novel and four known compounds belonging to the polyketide class has been carried out where their relative as well as absolute configurations have been determined using spectroscopic analysis techniques as well as by the comparison of theoretically calculated ECD spectrum and the experimental ECD spectrum, respectively. The structures of novel compounds 7 and 8 represent the first example of 2,5-dioxabicyclo[2.2.1]heptane pyrone backbone bearing a migrated polyene chain. The novel compounds 7, 8, and 5 exhibited impressive antibiotic properties against methicillin resistant Staphylococcus aureus (MRSA) with MIC value of around 0.5 and 1 μg/mL, respectively. Moreover, the new compounds 1, 7, and 8 displayed potent antibiotic activities with MIC values of around 4 μg/mL against the pathogenic Pseudomonas aeruginosa. Moreover, the MBC of the different potent compounds ranged from 1 to 128 μg/mL against MRSA, P. aeruginosa, and Klebsiella pneumoniae. In addition, the cytotoxic activities were also evaluated where new antibiotics 7 and 8 were not obviously harmful toward normal liver cell lines LO2, showing IC50 values above 100 μg/mL. As a consequence, the results from this study unveiled that cobalt stress is an effective strategy to discover novel antibiotics from microorganisms.

Bioactive Metabolites From The Mariana Trench Sediment-Derived Fungus Penicillium Sp. Sy2107

Isolation and Structure Elucidation of New Metabolites from the Mariana-Trench-Associated Fungus Aspergillus Sp. SY2601.

New Antifungal Metabolites from the Mariana Trench Sediment-Associated Actinomycete Streptomyces Sp. SY1965

A NEW EUDESMANE SESQUITERPENOID FROM THE MARINE-DERIVED FUNGUS Penicillium Sp. HK1-22

Isolation, Structural Elucidation, and Antimicrobial Evaluation of the Metabolites from a Marine-Derived Fungus Penicillium Sp. ZZ1283

Antimicrobial Metabolites from the Indonesian Mangrove Sediment-Derived Fungus Penicillium Chrysogenum Sp. ZZ1151

Bioactive Drimane Sesquiterpenoids and Isocoumarins from the Marine-Derived Fungus Penicillium Minioluteum ZZ1657

New Pyridone Alkaloids from Marine-Derived Fungus Penicillium Sp.

Peniciphenalenins A-F from the Culture of a Marine-Associated Fungus Penicillium Sp ZZ901

Novel Bioactive Penicipyrroether A and Pyrrospirone J from the Marine-Derived Penicillium Sp. ZZ380.

Hemiacetalmeroterpenoids A-C and Astellolide Q with Antimicrobial Activity from the Marine-Derived Fungus <i>Penicillium</i> sp. N-5

Secondary Metabolites and Antibacterial Activities of a Bruguiera Sexangula Var. Rhynchopetala-Derived Fungus Penicillium Sp. (J41221)

Bioassay-Directed Isolation of Antibacterial Metabolites from an Arthropod-Derived <i>Penicillium chrysogenum</i>

Antimicrobial Activities of a New Alkaloid from Marine-Derived Fungus, Penicillium sp. OM01

Structurally diverse secondary metabolites from a deep-sea-derived fungus Penicillium chrysogenum SCSIO 41001 and their biological evaluation.

New Cytotoxic Secondary Metabolites from Two Deep-Sea-Derived Fungi and the Co-Culture Impact on the Secondary Metabolic Patterns

Penicimeroterpenoids A–C, Meroterpenoids with Rearrangement Skeletons from the Marine-Derived Fungus Penicillium sp. SCSIO 41512

Stress-Driven Discovery of Novel Cryptic Antibiotics from a Marine Fungus Penicillium Sp. BB1122

Novel metabolites from the Mariana Trench-derived fungus Talaromyces sp. SY2250

New Alkaloids And Polyketides From The Marine Sponge-Derived Fungus Penicillium Sp. Scsio41015

New Polyketide and Sesquiterpenoid Derivatives from the Magellan Seamount‐Derived Fungus Penicillium rubens AS‐130